Abstract

This article explores effective treatment strategies for Autism Spectrum Disorders (ASD), focusing on innovative targeted therapies within the field of regenerative medicine. We reviewed and assessed the use of advanced regenerative techniques in treating ASD, highlighting new therapeutic modalities that address key pathological pathways associated with autism. The discussion includes cellular therapies, neuropeptide interventions, and treatments involving neuromediator precursors. Clinical outcomes were measured by improvements in behavioral, cognitive, and social functions. Patients with autism who received comprehensive biological therapy showed noticeable improvements in selfregulation and behavior within the initial weeks of treatment. By 2-3 months, significant progress was observed in eye contact, attention span, verbal responsiveness, and speech development. Follow-ups at six months indicated better communication skills and self management. The addition of neuropeptides during the maintenance phase led to marked reductions in anxiety and aggression, and improved social skills and communication. Longterm therapy demonstrated sustained enhancements in conversational abilities, decreased repetitive behaviors, and improved social and emotional interactions. The combination of novel biological therapies and nutraceuticals appears to offer a promising approach to managing ASD, with significant gains in behavioral and cognitive outcomes. These results suggest the potential of regenerative medicine in improving ASD treatment and highlight the need for further research to refine treatment protocols and confirm long-term benefits

Keywords

autism, autism spectrum disorders, stem cells, regenerative medicine, neurodevelopmental disorders, neuropeptides, behavioral therapy, cognitive development, social skills